Peptide Comparison
Rigin vs Syn-Coll
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Rigin and Syn-Coll share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Rigin | Syn-Coll | |
|---|---|---|
| Class | Cosmetic lipopeptide (anti-inflammatory) | Cosmetic lipopeptide (collagen) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Suppresses IL-6 secretion by fibroblasts; reduces inflammaging | TSP-1 mimic; activates latent TGF-β; stimulates collagen synthesis |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 2-4% | Topical 1-5% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 31 indexed | 12 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Rigin or Syn-Coll?
Rigin and Syn-Coll share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.
What is the difference between Rigin and Syn-Coll?
Rigin is classed as Cosmetic lipopeptide (anti-inflammatory); Syn-Coll is classed as Cosmetic lipopeptide (collagen). Reported mechanism: Rigin, Suppresses IL-6 secretion by fibroblasts; reduces inflammaging; Syn-Coll, TSP-1 mimic; activates latent TGF-β; stimulates collagen synthesis. Reported half-life: Rigin, Topical; Syn-Coll, Topical. Routes in published studies: Rigin, Topical; Syn-Coll, Topical.
Which has stronger evidence, Rigin or Syn-Coll?
Rigin and Syn-Coll sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Rigin is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 31 indexed studies. Syn-Coll is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 12 indexed studies.
Which is more accessible, Rigin or Syn-Coll?
Neither Rigin nor Syn-Coll is an FDA-approved drug. Catalog status: Rigin, Cosmetic; Syn-Coll, Cosmetic.
Are Rigin and Syn-Coll ever combined?
Rigin and Syn-Coll appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…